Breaking News
Home >> Business >> Pain Therapeutics Market (5.3% CAGR) 2017-2025: Global Business Growth, Size and Forecast

Pain Therapeutics Market (5.3% CAGR) 2017-2025: Global Business Growth, Size and Forecast

According to the latest market report published by Acute Market Reports, the global pain therapeutics market was valued at US$ 53.2 billion in 2016 and is expected to reach US$ 85.4 billion by 2025, increasing to CAGR by 5.3 per cent from 2017 to 2025.

Market Insights

Global pain therapeutics market is segmented on the basis of major drug class types such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants and others. Due to their proven effectiveness, the demand for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) is highest in market. However, stringent regulatory guidelines for the use of opioid drugs is negatively impacting the growth of opioids market.

Browse Full Report Originally Published by Acute Market Reports at

For this study, pain therapeutics market is categorized on the basis of major pain type such as nociceptive pain (somatic pain, visceral pain and cutaneous pain), neuropathic pain and psychogenic pain. At present, the demand for nociceptive pain therapeutics is the highest in market, due to its widespread incidence. Pain therapeutics for neuropathic pain is anticipated to show the fastest market growth over the forecast period due to higher number of unmet needs, increasing number of disease such as diabetes, neuralgia, cancer etc. Furthermore, presence of ideal pipeline drugs such as TV-45070, PF-04383119, AGN-203818, GRO-12, REGN-475, KRN-5500, xpf-002 etc. would assist the growth of neuropathic pain therapeutics market over the forecast period.  

At present, North America is the largest regional market for pain therapeutics with the United States accounting for the highest market share due to higher cost of therapeutics, massive R&D activities for drug discovery, higher number of target population, high healthcare awareness and increase in number of pain management centers. However, Asia Pacific is anticipated to grow significantly over the forecast period due to large pool of target population, developing economic condition and growing healthcare expenditure.

Market Competition Assessment:

Pain therapeutics market is highly competitive and involves large number of manufacturers. However, market is dominated by few players such as Abbott Laboratories, AstraZeneca Plc., Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC., Johnson & Johnson Services Inc., Mallinckrodt Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A. and others.

Key Market Movements:

  • Factors such as increase in demand for pain therapeutics, growing number of surgeries, rising number of chronic disease, increasing number accidents related injuries and trauma, strong presence of pipeline drugs would drive pain therapeutics market growth during forecast period
  • Significant unmet needs for treatment of neuropathic pain, key players in the market are focusing on innovation and advancement in pain therapeutics would further influence the growth of pain therapeutics market

You can get the sample copy of this research by Acute Market Reports here:

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Pain Therapeutics Market Portraiture
2.1.1. Global Pain Therapeutics Market, by Drug Class, 2016
2.1.2. Global Pain Therapeutics Market, by Pain Type, 2016
2.1.3. Global Pain Therapeutics Market, by Geography, 2016

Chapter 3. Pain Therapeutics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2016
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Pipeline Analysis of Pain Therapeutics
4.1. Overview
4.2. Projected Sales of Phase III Pain Therapeutics Estimated Till 2025 (US$ Bn)
4.3. Tabular Representation of Phase II and I Pain Therapeutics

Chapter 5. Global Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
5.1. Overview
5.1.1. Attractive Investment Proposition, by Drug Class, 2016
5.2. Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.3. Opioids
5.4. Anesthetics
5.5. Anticonvulsants
5.6. Corticosteroids
5.7. Antidepressants
5.8. Other

Chapter 6. Global Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
6.1. Overview
6.2. Nociceptive Pain
6.2.1. Somatic Pain
6.2.2. Visceral Pain
6.2.3. Cutaneous Pain
6.3. Neuropathic Pain
6.4. Psychogenic Pain

Chapter 7. Global Pain Therapeutics Market, by Geography, 2015 – 2025

You can get the sample copy of this research by Acute Market Reports here:

About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
(US/CANADA) Ph.: +1-855-455-8662

Leave a Reply

Your email address will not be published. Required fields are marked *